Clopidogrel-induced acute generalized exanthematous pustulosis with elevated Th17 cytokine levels as determined by a drug lymphocyte stimulation test

British Journal of Dermatology

Volumn 162, Issue 6, 2010, Pages 1402-1403

  Nakamizo, S ^a   Kobayashi, S ^a   Usui, T ^a   Miyachi, Y ^a   Kabashima, K ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Acute generalized exanthematous pustulosis; Clopidogrel; Drug lymphocyte stimulation test; Interleukin 17; Th17

Indexed keywords

CLOPIDOGREL; STEROID;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; AGED; CASE REPORT; CD4+ T LYMPHOCYTE; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; LETTER; LIVER FUNCTION TEST; LYMPHOCYTE TRANSFORMATION TEST; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; PSORIASIS VULGARIS; TH17 CELL;

ACUTE DISEASE; ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; AGED; HUMANS; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MALE; PLATELET AGGREGATION INHIBITORS; TH17 CELLS; TICLOPIDINE;

EID: 77952720004     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09705.x     Document Type: Letter

References (5)

1. Roujeau JC, Bioulac-Sage P, Bourseau C et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991 127 : 1333 1338.
2. Sidoroff A, Halevy S, Bavinck JN et al. Acute generalized exanthematous pustulosis (AGEP) - a clinical reaction pattern. J Cutan Pathol 2001 28 : 113 119. (Pubitemid 32112994)
3. Chaabane A, Aouam K, Gassab L et al. Acute generalized exanthematous pustulosis (AGEP) induced by cefotaxime. Fundam Clin Pharmacol. 2009 Nov 18 [Epub ahead of print].
4. Britschgi M, Steiner UC, Schmid S et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001 107 : 1433 1441.
5. Britschgi M, Pichler WJ. Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr Opin Allergy Clin Immunol 2002 2 : 325 331.